RENN [Renren] SC 13G/A: SCHEDULE 13G/A (Amendment No. 4)* Renren Inc. (Name

[SCHEDULE 13G/A (Amendment No. 4)* Renren Inc. (Name of Issuer) Class A Ordinary Shares, par value US$0.001 per share (Title of Class of Securities) 759892300** (CUSIP Number) September 10, 2020 (Date of event which requires filing of this statement) ☐ Rule 13d-1(b) ☒ Rule 13d-1(c) ☐ Rule 13d-1(d) (P]

NCTY [The9] F-1/A: (Original Filing)

[] [THE9 LIMITED CLASS A ORDINARY SHARES, PAR VALUE US$0.01 PER SHARE IN THE FORM OF AMERICAN DEPOSITARY SHARES UNDERWRITING AGREEMENT [●], 2020 Maxim Group LLC As Representative of the several Underwriters named in Schedule I attached hereto Ladies and Gentlemen: Company Underwriters Agreement” Repr]

By | 2020-10-01T13:50:38+00:00 September 23rd, 2020|Categories: Chinese Stocks, NCTY, SEC Original|Tags: , , , , , |0 Comments

NCTY [The9] F-1/A:

[] [THE9 LIMITED CLASS A ORDINARY SHARES, PAR VALUE US$0.01 PER SHARE IN THE FORM OF AMERICAN DEPOSITARY SHARES UNDERWRITING AGREEMENT [●], 2020 Maxim Group LLC As Representative of the several Underwriters named in Schedule I attached hereto Ladies and Gentlemen: Company Underwriters Agreement” Repr]

By | 2020-10-01T13:50:42+00:00 September 23rd, 2020|Categories: Chinese Stocks, NCTY, Webplus ver|Tags: , , , , , |0 Comments

SVA [SINOVAC BIOTECH] 6-K: (Original Filing)

[Sinovac’s Coronavac, SARS-CoV-2 Vaccine (Vero Cell), Inactivated, Announces Approval for Phase I/II Clinical Trial in Adolescents and Children BEIJING, China, September 23, 2020 /Business Wire/ -- Sinovac Biotech Ltd. (NASDAQ: SVA) (“Sinovac” or the “Company”), a leading provider of biopharmaceutica]

By | 2020-10-01T15:36:44+00:00 September 23rd, 2020|Categories: Chinese Stocks, SEC Original, SVA|Tags: , , , , , |0 Comments

SVA [SINOVAC BIOTECH] 6-K: Sinovac’s Coronavac, SARS-CoV-2 Vaccine (Vero Cell), Inactivated, Announces

[Sinovac’s Coronavac, SARS-CoV-2 Vaccine (Vero Cell), Inactivated, Announces Approval for Phase I/II Clinical Trial in Adolescents and Children BEIJING, China, September 23, 2020 /Business Wire/ -- Sinovac Biotech Ltd. (NASDAQ: SVA) (“Sinovac” or the “Company”), a leading provider of biopharmaceutica]

By | 2020-10-01T15:36:47+00:00 September 23rd, 2020|Categories: Chinese Stocks, SVA, Webplus ver|Tags: , , , , , |0 Comments

SGOC [SGOCO] 6-K: (Original Filing)

[SGOCO Group, Ltd. Appoints New Director The Company today announced that the Board of Directors of the Company has appointed Mr. Mark Leonard Tan (“Mr. Tan”) as the director of the Company, effective on September 23, 2020 to replace Mr. Hok Fung Wai who notified his resignation from the Board, effec]

SGOC [SGOCO] 6-K: SGOCO Group, Ltd. Appoints New Director The Company

[SGOCO Group, Ltd. Appoints New Director The Company today announced that the Board of Directors of the Company has appointed Mr. Mark Leonard Tan (“Mr. Tan”) as the director of the Company, effective on September 23, 2020 to replace Mr. Hok Fung Wai who notified his resignation from the Board, effec]

SNP [CHINA PETROLEUM & CHEMICAL] 6-K: (Original Filing)

[This Form 6-K consists of: 1. 2. Announcement 1 (a joint stock limited company incorporated in the People’s Republic of China with limited liability) (Stock Code: 00386) Resignation of Director The board of directors (the " Board ") of China Petroleum & Chemical Corporation (" Sinopec Corp. " or the]

By | 2020-10-01T09:26:24+00:00 September 23rd, 2020|Categories: Chinese Stocks, SEC Original, SNP|Tags: , , , , , |0 Comments
Skip to toolbar